Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Gyre Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 40 | 29 | −11 |
| Shares | 3.37M | 2.27M | −1.10M (−32.7%) |
| Value | $707.6K | $796.3K | +$88.7K (+12.5%) |
New holders (3)
Institutions that held Gyre Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 48,633 | $17.0K | 0.00% |
| UBS Group AG | 25,983 | $9.15K | 0.00% |
| Cubist Systematic Strategies, LLC | 14,683 | $5.16K | 0.00% |
Sold out (14)
Institutions that held Gyre Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 272,313 | $56.0K |
| Bank of New York Mellon Corp | 200,638 | $41.5K |
| Buckingham Strategic Wealth, LLC | 43,100 | $22.7K |
| HRT Financial LP | 81,851 | $16.0K |
| Two Sigma Securities, LLC | 50,750 | $10.5K |
| Ergoteles LLC | 50,314 | $10.4K |
| Simplex Trading, LLC | 44,435 | $9.00K |
| Janney Montgomery Scott LLC | 40,000 | $8.00K |
| Goldman Sachs Group Inc | 21,423 | $4.43K |
| Citadel Advisors LLC | 15,855 | $3.28K |
| Arete Wealth Advisors, LLC | 10,345 | $2.00K |
| Advisory Services Network, LLC | 1,000 | $207 |
| FMR LLC | 1 | $0 |
| Royal Bank of Canada | 10 | $0 |